Phase I-II study of Plitidepsin and Dacarbazine as first-line therapy for advanced melanoma.
Plummer, R Brown, E Zaucha, R Moiseyenko, V Demidov, L Soriano, V Chmielowska, E Andrés, R Kudryavtseva, G
Plummer, R
Brown, E
Zaucha, R
Moiseyenko, V
Demidov, L
Soriano, V
Chmielowska, E
Andrés, R
Kudryavtseva, G
Citations
Altmetric:
Abstract
This phase I-II trial compared plitidepsin 1-h infusion alone or combined with dacarbazine (DTIC) 1-h infusion as front-line therapy for advanced melanoma.
Description
Date
2013-09-17
Publisher
Collections
Keywords
Type
Article
Citation
Phase I-II study of Plitidepsin and Dacarbazine as first-line therapy for advanced melanoma. 2013, 109 (6):1451-9 Br J Cancer